List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)
Research projects conducted under the remit of the PRAC impact strategy
Pharmacovigilance: Overview
Human medicines European public assessment report (EPAR): Myocet liposomal (previously Myocet), doxorubicin, Date of authorisation: 13/07/2000, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): PecFent, fentanyl, Date of authorisation: 31/08/2010, Revision: 25, Status: Authorised
On behalf of the French and the Belgian Societies of Internal Medicine we kindly invite you to participate in a survey to investigate the role of internal medicine in the care of patients with long COVID.
Salbutamol inhalation products suppy shortage
Referral: Synapse Article 31 referrals European Commission final decision, 21/03/2024, 24/05/2024, 05/06/2024
Referral: Ibuprofen NVT, ibuprofen Article 29(4) referrals European Commission final decision, 22/02/2024, 10/05/2024, 05/06/2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 2 December 2024 to 6 December 2024